Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Acadia Healthcare Company, Inc. stock logo
ACHC
Acadia Healthcare
$21.90
-0.7%
$22.82
$20.36
$82.41
$2.02B0.941.80 million shs2.80 million shs
HealthEquity, Inc. stock logo
HQY
HealthEquity
$104.88
+0.0%
$98.01
$65.01
$116.65
$9.07B0.49851,782 shs958,705 shs
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
$39.80
+0.1%
$33.97
$23.95
$52.34
$6.33B0.181.58 million shs2.48 million shs
Tenet Healthcare Corporation stock logo
THC
Tenet Healthcare
$173.64
+0.6%
$157.06
$109.82
$177.32
$16.13B1.651.83 million shs1.55 million shs
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Acadia Healthcare Company, Inc. stock logo
ACHC
Acadia Healthcare
0.00%+1.58%-3.82%-27.77%-67.57%
HealthEquity, Inc. stock logo
HQY
HealthEquity
0.00%+3.53%+3.73%+18.68%+21.67%
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
0.00%+6.39%+18.31%+31.92%-16.49%
Tenet Healthcare Corporation stock logo
THC
Tenet Healthcare
0.00%+3.28%+2.86%+28.91%+30.53%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Acadia Healthcare Company, Inc. stock logo
ACHC
Acadia Healthcare
4.7848 of 5 stars
4.33.00.05.01.90.02.5
HealthEquity, Inc. stock logo
HQY
HealthEquity
3.6565 of 5 stars
3.53.00.00.02.72.51.9
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
4.1017 of 5 stars
3.42.00.03.02.53.30.6
Tenet Healthcare Corporation stock logo
THC
Tenet Healthcare
4.5082 of 5 stars
2.43.00.04.32.72.52.5
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Acadia Healthcare Company, Inc. stock logo
ACHC
Acadia Healthcare
2.60
Moderate Buy$47.94118.92% Upside
HealthEquity, Inc. stock logo
HQY
HealthEquity
3.00
Buy$118.0912.60% Upside
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
2.72
Moderate Buy$57.8845.41% Upside
Tenet Healthcare Corporation stock logo
THC
Tenet Healthcare
2.89
Moderate Buy$183.945.93% Upside

Current Analyst Ratings Breakdown

Latest HQY, ACHC, IONS, and THC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/26/2025
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$50.00
6/12/2025
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$45.00 ➝ $48.00
6/9/2025
Tenet Healthcare Corporation stock logo
THC
Tenet Healthcare
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$175.00 ➝ $210.00
6/5/2025
HealthEquity, Inc. stock logo
HQY
HealthEquity
Barrington Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$112.00 ➝ $125.00
6/5/2025
HealthEquity, Inc. stock logo
HQY
HealthEquity
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$98.00 ➝ $115.00
6/4/2025
HealthEquity, Inc. stock logo
HQY
HealthEquity
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$94.00 ➝ $104.00
6/4/2025
HealthEquity, Inc. stock logo
HQY
HealthEquity
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$112.00 ➝ $117.00
6/4/2025
HealthEquity, Inc. stock logo
HQY
HealthEquity
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetMarket Outperform ➝ Market Outperform$110.00 ➝ $117.00
6/4/2025
HealthEquity, Inc. stock logo
HQY
HealthEquity
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$110.00 ➝ $125.00
6/2/2025
Acadia Healthcare Company, Inc. stock logo
ACHC
Acadia Healthcare
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold
6/2/2025
Tenet Healthcare Corporation stock logo
THC
Tenet Healthcare
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
(Data available from 6/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Acadia Healthcare Company, Inc. stock logo
ACHC
Acadia Healthcare
$3.15B0.64$4.93 per share4.44$33.09 per share0.66
HealthEquity, Inc. stock logo
HQY
HealthEquity
$1.20B7.56$4.26 per share24.60$24.40 per share4.30
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
$705M8.99N/AN/A$3.73 per share10.67
Tenet Healthcare Corporation stock logo
THC
Tenet Healthcare
$20.67B0.78$21.10 per share8.23$61.20 per share2.84
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Acadia Healthcare Company, Inc. stock logo
ACHC
Acadia Healthcare
$255.61M$2.0310.796.464.105.94%8.72%4.46%7/30/2025 (Estimated)
HealthEquity, Inc. stock logo
HQY
HealthEquity
$96.70M$1.3776.5536.931.619.80%11.01%6.77%9/2/2025 (Estimated)
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
-$453.90M-$2.99N/AN/AN/A-63.65%-91.85%-15.77%7/30/2025 (Estimated)
Tenet Healthcare Corporation stock logo
THC
Tenet Healthcare
$3.20B$15.1211.4812.921.277.09%22.58%4.29%7/22/2025 (Confirmed)

Latest HQY, ACHC, IONS, and THC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/22/2025Q2 2025
Tenet Healthcare Corporation stock logo
THC
Tenet Healthcare
$2.84N/AN/AN/A$5.16 billionN/A
6/3/2025Q1 2026
HealthEquity, Inc. stock logo
HQY
HealthEquity
$0.81$0.97+$0.16$0.61$322.25 million$330.80 million
5/12/2025Q1 2025
Acadia Healthcare Company, Inc. stock logo
ACHC
Acadia Healthcare
$0.35$0.40+$0.05$0.09$769.90 million$770.51 million
4/30/2025Q1 2025
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
-$1.07-$0.93+$0.14-$0.93$144.31 million$132.00 million
4/29/2025Q1 2025
Tenet Healthcare Corporation stock logo
THC
Tenet Healthcare
$3.11$4.36+$1.25$4.27$5.15 billion$5.22 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Acadia Healthcare Company, Inc. stock logo
ACHC
Acadia Healthcare
N/AN/AN/AN/AN/A
HealthEquity, Inc. stock logo
HQY
HealthEquity
N/AN/AN/AN/AN/A
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
N/AN/AN/AN/AN/A
Tenet Healthcare Corporation stock logo
THC
Tenet Healthcare
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Acadia Healthcare Company, Inc. stock logo
ACHC
Acadia Healthcare
0.72
1.35
1.35
HealthEquity, Inc. stock logo
HQY
HealthEquity
0.50
4.06
4.06
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
2.63
9.66
9.62
Tenet Healthcare Corporation stock logo
THC
Tenet Healthcare
2.23
1.78
1.70

Institutional Ownership

CompanyInstitutional Ownership
Acadia Healthcare Company, Inc. stock logo
ACHC
Acadia Healthcare
N/A
HealthEquity, Inc. stock logo
HQY
HealthEquity
99.55%
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
93.86%
Tenet Healthcare Corporation stock logo
THC
Tenet Healthcare
95.44%

Insider Ownership

CompanyInsider Ownership
Acadia Healthcare Company, Inc. stock logo
ACHC
Acadia Healthcare
2.00%
HealthEquity, Inc. stock logo
HQY
HealthEquity
1.50%
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
2.71%
Tenet Healthcare Corporation stock logo
THC
Tenet Healthcare
0.81%
CompanyEmployeesShares OutstandingFree FloatOptionable
Acadia Healthcare Company, Inc. stock logo
ACHC
Acadia Healthcare
25,50092.12 million90.28 millionOptionable
HealthEquity, Inc. stock logo
HQY
HealthEquity
3,12086.47 million85.18 millionOptionable
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
1,069159.16 million154.85 millionOptionable
Tenet Healthcare Corporation stock logo
THC
Tenet Healthcare
98,00092.89 million92.13 millionOptionable

Recent News About These Companies

2 hospitals tap former Tenet facility CEO as CFO
Tenet Texas hospital taps new CFO

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Acadia Healthcare stock logo

Acadia Healthcare NASDAQ:ACHC

$21.90 -0.16 (-0.73%)
Closing price 06/27/2025 04:00 PM Eastern
Extended Trading
$21.62 -0.29 (-1.30%)
As of 05:18 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities. Acadia Healthcare Company, Inc. was founded in 2005 and is headquartered in Franklin, Tennessee.

HealthEquity stock logo

HealthEquity NASDAQ:HQY

$104.88 +0.02 (+0.02%)
Closing price 06/27/2025 04:00 PM Eastern
Extended Trading
$101.57 -3.31 (-3.16%)
As of 04:03 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc. was incorporated in 2002 and is based in Draper, Utah.

Ionis Pharmaceuticals stock logo

Ionis Pharmaceuticals NASDAQ:IONS

$39.80 +0.02 (+0.05%)
Closing price 06/27/2025 04:00 PM Eastern
Extended Trading
$40.35 +0.55 (+1.38%)
As of 04:48 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an antisense injection for the treatment of polyneuropathy caused by hereditary transthyretin amyloidosis in adults; and WAYLIVRA, an antisense medicine for treatment for familial chylomicronemia syndrome (FCS) and familial partial lipodystrophy. It also develops medicines for various indications that are in phase 3 study, including Eplontersen as a monthly self-administered subcutaneous injection to treat all types of ATTR; Olezarsen for patients with FCS and severe hypertriglyceridemia (SHTG); Donidalorsen for patients with hereditary angioedema; ION363 for patients with amyotrophic lateral sclerosis; Tofersen to inhibit the production of superoxide dismutase 1; Pelacarsen for patients with established cardiovascular disease and elevated lipoprotein(a); and Bepirovirsen to inhibit the production of viral proteins associated with hepatitis B virus. In addition, the company develops IONIS-FB-LRx to inhibit the production of complement factor B and the alternative complement pathway; and ION224 to reduce the production of diacylglycerol acyltransferase 2. It has a strategic collaboration with Biogen for the treatment of neurological disorders; and collaboration and license agreement with Metagenomi, Inc, AstraZeneca, Bayer AG, GlaxoSmithKline plc, Novartis, Roche, Swedish Orphan Biovitrum AB, and PTC Therapeutics. The company was incorporated in 1989 and is based in Carlsbad, California.

Tenet Healthcare stock logo

Tenet Healthcare NYSE:THC

$173.64 +1.08 (+0.63%)
As of 06/27/2025 03:58 PM Eastern

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and/or coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; tertiary care services, such as cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services; quaternary care services in heart and kidney transplants; and limb salvaging vascular procedure, acute level 1 trauma, intravascular stroke care, minimally invasive cardiac valve replacement, imaging, surgical robotic, and telemedicine access services. In addition, it offers a range of procedures and services, such as orthopedics, total joint replacement, and spinal and other musculoskeletal procedures; gastroenterology; pain management; otolaryngology; ophthalmology; and urology. It operates hospitals, ambulatory surgery centers, imaging centers, surgical hospitals, off-campus emergency departments, and micro-hospitals. Tenet Healthcare Corporation was founded in 1967 and is headquartered in Dallas, Texas.